KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Total Debt (2016 - 2025)

Quest Diagnostics' Total Debt history spans 17 years, with the latest figure at $5.7 billion for Q4 2025.

  • For Q4 2025, Total Debt fell 8.78% year-over-year to $5.7 billion; the TTM value through Dec 2025 reached $5.7 billion, down 8.78%, while the annual FY2025 figure was $5.7 billion, 8.78% down from the prior year.
  • Total Debt for Q4 2025 was $5.7 billion at Quest Diagnostics, roughly flat from $5.7 billion in the prior quarter.
  • Across five years, Total Debt topped out at $6.3 billion in Q3 2024 and bottomed at $4.0 billion in Q1 2023.
  • The 5-year median for Total Debt is $4.3 billion (2023), against an average of $4.7 billion.
  • The largest annual shift saw Total Debt fell 12.38% in 2021 before it surged 47.08% in 2024.
  • A 5-year view of Total Debt shows it stood at $4.0 billion in 2021, then dropped by 0.8% to $4.0 billion in 2022, then grew by 18.42% to $4.7 billion in 2023, then soared by 31.91% to $6.2 billion in 2024, then fell by 8.78% to $5.7 billion in 2025.
  • Per Business Quant, the three most recent readings for DGX's Total Debt are $5.7 billion (Q4 2025), $5.7 billion (Q3 2025), and $5.7 billion (Q2 2025).